Ting-Chuan Lee Sells 109,988 Shares of Ainos (NASDAQ:AIMD) Stock

Ainos, Inc. (NASDAQ:AIMD) Director Ting-Chuan Lee sold 109,988 shares of the firm’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $1.90, for a total value of $208,977.20. Following the completion of the sale, the director directly owned 807,417 shares of the company’s stock, valued at $1,534,092.30. This trade represents a 11.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Ainos Stock Up 7.0%

Shares of AIMD opened at $2.74 on Friday. Ainos, Inc. has a 52-week low of $1.26 and a 52-week high of $4.50. The company has a market capitalization of $23.34 million, a PE ratio of -0.95 and a beta of 2.29. The stock has a fifty day simple moving average of $1.69 and a two-hundred day simple moving average of $1.83. The company has a quick ratio of 0.50, a current ratio of 0.55 and a debt-to-equity ratio of 1.58.

Ainos (NASDAQ:AIMD) last issued its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Ainos

Several hedge funds and other institutional investors have recently made changes to their positions in AIMD. Mariner LLC purchased a new position in shares of Ainos in the 4th quarter valued at about $37,000. Two Sigma Investments LP purchased a new position in shares of Ainos in the 3rd quarter valued at about $80,000. DRW Securities LLC boosted its stake in shares of Ainos by 272.6% in the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock valued at $109,000 after buying an additional 48,439 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in shares of Ainos by 13.1% in the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock valued at $109,000 after buying an additional 7,700 shares during the period.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.